Invention Grant
- Patent Title: Proteostasis regulators
-
Application No.: US15402628Application Date: 2017-01-10
-
Publication No.: US10532996B2Publication Date: 2020-01-14
- Inventor: Megan Foley , Bradley Tait , Matthew Cullen
- Applicant: Proteostasis Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Proteostasis Therapeutics, Inc.
- Current Assignee: Proteostasis Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Armstrong Teasdale, LLP
- Main IPC: C07D403/06
- IPC: C07D403/06 ; C07D405/06 ; C07D401/06 ; C07D249/06 ; C07D207/333 ; C07D207/337 ; C07D231/12 ; C07D263/32 ; C07D275/02 ; C07D295/185 ; C07D333/20 ; C07D471/04 ; C07D333/22
Abstract:
The present invention is directed to compounds having the Formulae (Ia-Ie), (II), (IIIa-IIId), (IVa-IVc), (Va-Vb), (VIa-VIe), (VII), (VIIIa-VIIIc), and (IX), pharmaceutically acceptable salts, prodrugs and solvates thereof, compositions of any of thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis comprising an effective amount of these compounds.
Public/Granted literature
- US20170247355A1 PROTEOSTASIS REGULATORS Public/Granted day:2017-08-31
Information query
